| Literature DB >> 3709245 |
R Carter, J S Williams, J Berry, M Peavler, D Griner, B Tiep.
Abstract
There is much recent evidence that patients with chronic pulmonary disease who are hypoxemic benefit from continuous therapy with oxygen. These benefits include reduction in symptoms of cor pulmonale, reduction in mortality, and improvement in quality of life. Oxygen therapy is very expensive, and steady-flow delivery of oxygen is wasteful, since almost the entire benefit of the oxygen presented to the patient occurs at the very beginning of inspiration. We previously described a conserver nasal cannula (CNC) which stores oxygen during exhalation for delivery during subsequent inspirations. The CNC achieves adequate arterial oxygen saturation (SaO2) at one fourth to one half of the flow in liters of steady-flow oxygen delivery. Because some patients found the mustache configuration objectionable, a pendant nasal cannula (PNC) was designed, displacing the reservoir off of the face and onto the anterior wall of the chest. While both cannulas require some breathing by nose to function, the PNC is more esthetically acceptable. No studies with exercise have been reported using the PNC. We evaluated the PNC during treadmill exercise in ten subjects with chronic obstructive pulmonary disease and hypoxemia on exercise. We compared the PNC with steady-flow oxygen during steady level treadmill walking sufficient to cause oxygen desaturation while breathing room air at oxygen presentations of 0.5 through 3.0 L/min. At comparable workloads the SaO2 achieved by PNC required one third of the oxygen flow required by steady-flow oxygen to achieve an equivalent SaO2. These differences were statistically significant (p less than 0.01). We conclude that the PNC provides effective delivery of oxygen during exercise, as well as at rest, while minimizing oxygen flow rate and thus substantially reducing the economic burden normally associated with supplemental oxygen delivery.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3709245 DOI: 10.1378/chest.89.6.806
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410